Literature DB >> 30795982

Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals.

Carole Henry1, Nai-Ying Zheng2, Min Huang2, Alexandra Cabanov2, Karla Thatcher Rojas2, Kaval Kaur2, Sarah F Andrews2, Anna-Karin E Palm2, Yao-Qing Chen2, Yang Li3, Katerina Hoskova2, Henry A Utset2, Marcos C Vieira4, Jens Wrammert5, Rafi Ahmed6, Jeanne Holden-Wiltse7, David J Topham8, John J Treanor9, Hildegund C Ertl10, Kenneth E Schmader11, Sarah Cobey4, Florian Krammer12, Scott E Hensley3, Harry Greenberg13, Xiao-Song He13, Patrick C Wilson14.   

Abstract

Influenza is a leading cause of death in the elderly, and the vaccine protects only a fraction of this population. A key aspect of antibody-mediated anti-influenza virus immunity is adaptation to antigenically distinct epitopes on emerging strains. We examined factors contributing to reduced influenza vaccine efficacy in the elderly and uncovered a dramatic reduction in the accumulation of de novo immunoglobulin gene somatic mutations upon vaccination. This reduction is associated with a significant decrease in the capacity of antibodies to target the viral glycoprotein, hemagglutinin (HA), and critical protective epitopes surrounding the HA receptor-binding domain. Immune escape by antigenic drift, in which viruses generate mutations in key antigenic epitopes, becomes highly exaggerated. Because of this reduced adaptability, most B cells activated in the elderly cohort target highly conserved but less potent epitopes. Given these findings, vaccines driving immunoglobulin gene somatic hypermutation should be a priority to protect elderly individuals.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  elderly population; immunoglobulin genes; influenza vaccine; monoclonal antibodies

Mesh:

Substances:

Year:  2019        PMID: 30795982      PMCID: PMC6452894          DOI: 10.1016/j.chom.2019.01.002

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  40 in total

1.  Age-related alterations of somatic hypermutation and CDR3 lengths in human Vkappa4-expressing B lymphocytes.

Authors:  D Troutaud; M Drouet; C Decourt; C Le Morvan; M Cogné
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

Review 2.  Community-acquired pneumonia in the elderly.

Authors:  T J Marrie
Journal:  Clin Infect Dis       Date:  2000-10-20       Impact factor: 9.079

3.  Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies.

Authors:  Sanae Sasaki; Meghan Sullivan; Carlos F Narvaez; Tyson H Holmes; David Furman; Nai-Ying Zheng; Madhuri Nishtala; Jens Wrammert; Kenneth Smith; Judith A James; Cornelia L Dekker; Mark M Davis; Patrick C Wilson; Harry B Greenberg; Xiao-Song He
Journal:  J Clin Invest       Date:  2011-07-25       Impact factor: 14.808

4.  Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.

Authors:  Gui-Mei Li; Christopher Chiu; Jens Wrammert; Megan McCausland; Sarah F Andrews; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Xinyan Qu; Srilatha Edupuganti; Mark Mulligan; Suman R Das; Jonathan W Yewdell; Aneesh K Mehta; Patrick C Wilson; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

5.  Impact of age on hypermutation of immunoglobulin variable genes in humans.

Authors:  K Rosner; D B Winter; C Kasmer; G L Skovgaard; R E Tarone; V A Bohr; P J Gearhart
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

Review 6.  Vaccination in the elderly: an immunological perspective.

Authors:  Wilbur H Chen; Bernard F Kozlovsky; Rita B Effros; Beatrix Grubeck-Loebenstein; Robert Edelman; Marcelo B Sztein
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

7.  Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.

Authors:  Jens Wrammert; Dimitrios Koutsonanos; Gui-Mei Li; Srilatha Edupuganti; Jianhua Sui; Michael Morrissey; Megan McCausland; Ioanna Skountzou; Mady Hornig; W Ian Lipkin; Aneesh Mehta; Behzad Razavi; Carlos Del Rio; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Zahida Ali; Kaval Kaur; Sarah Andrews; Rama Rao Amara; Youliang Wang; Suman Ranjan Das; Christopher David O'Donnell; Jon W Yewdell; Kanta Subbarao; Wayne A Marasco; Mark J Mulligan; Richard Compans; Rafi Ahmed; Patrick C Wilson
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

8.  Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults.

Authors:  Carlos A DiazGranados; Andrew J Dunning; Corwin A Robertson; H Keipp Talbot; Victoria Landolfi; David P Greenberg
Journal:  Clin Infect Dis       Date:  2016-02-21       Impact factor: 9.079

9.  Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.

Authors:  Raffael Nachbagauer; Angela Choi; Ruvim Izikson; Manon M Cox; Peter Palese; Florian Krammer
Journal:  MBio       Date:  2016-01-19       Impact factor: 7.867

10.  Lineage structure of the human antibody repertoire in response to influenza vaccination.

Authors:  Ning Jiang; Jiankui He; Joshua A Weinstein; Lolita Penland; Sanae Sasaki; Xiao-Song He; Cornelia L Dekker; Nai-Ying Zheng; Min Huang; Meghan Sullivan; Patrick C Wilson; Harry B Greenberg; Mark M Davis; Daniel S Fisher; Stephen R Quake
Journal:  Sci Transl Med       Date:  2013-02-06       Impact factor: 17.956

View more
  58 in total

Review 1.  How repertoire data are changing antibody science.

Authors:  Claire Marks; Charlotte M Deane
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

2.  Understanding the Heterogeneous Population of Age-Associated B Cells and Their Contributions to Autoimmunity and Immune Response to Pathogens.

Authors:  Olivia Kugler-Umana; Priyadharshini Devarajan; Susan L Swain
Journal:  Crit Rev Immunol       Date:  2020       Impact factor: 2.214

3.  Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.

Authors:  Ericka Kirkpatrick; Carole Henry; Meagan McMahon; Kaijun Jiang; Shirin Strohmeier; Harm van Bakel; Patrick C Wilson; Florian Krammer
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

4.  Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans.

Authors:  Haley L Dugan; Jenna J Guthmiller; Philip Arevalo; Min Huang; Yao-Qing Chen; Karlynn E Neu; Carole Henry; Nai-Ying Zheng; Linda Yu-Ling Lan; Micah E Tepora; Olivia Stovicek; Dalia Bitar; Anna-Karin E Palm; Christopher T Stamper; Siriruk Changrob; Henry A Utset; Lynda Coughlan; Florian Krammer; Sarah Cobey; Patrick C Wilson
Journal:  Sci Transl Med       Date:  2020-12-09       Impact factor: 17.956

Review 5.  Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs.

Authors:  Santosh Dhakal; Sabra L Klein
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

6.  Fifty Years of Influenza A(H3N2) Following the Pandemic of 1968.

Authors:  Barbara J Jester; Timothy M Uyeki; Daniel B Jernigan
Journal:  Am J Public Health       Date:  2020-05       Impact factor: 9.308

Review 7.  Age-related factors that affect B cell responses to vaccination in mice and humans.

Authors:  Daniela Frasca; Bonnie B Blomberg; Denisse Garcia; Spencer R Keilich; Laura Haynes
Journal:  Immunol Rev       Date:  2020-06-02       Impact factor: 12.988

8.  Original Antigenic Sin: Friend or Foe in Developing a Broadly Cross-Reactive Vaccine to Influenza?

Authors:  Priyadharshini Devarajan; Susan L Swain
Journal:  Cell Host Microbe       Date:  2019-03-13       Impact factor: 21.023

9.  Relative and Absolute Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults-United States, 2015-2017.

Authors:  Joshua D Doyle; Lauren Beacham; Emily T Martin; H Keipp Talbot; Arnold Monto; Manjusha Gaglani; Donald B Middleton; Fernanda P Silveira; Richard K Zimmerman; Elif Alyanak; Emily R Smith; Brendan L Flannery; Melissa Rolfes; Jill M Ferdinands
Journal:  Clin Infect Dis       Date:  2021-03-15       Impact factor: 9.079

10.  Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways.

Authors:  Ramin Sedaghat Herati; Luisa Victoria Silva; Laura A Vella; Alexander Muselman; Cecile Alanio; Bertram Bengsch; Raj K Kurupati; Senthil Kannan; Sasikanth Manne; Andrew V Kossenkov; David H Canaday; Susan A Doyle; Hildegund C J Ertl; Kenneth E Schmader; E John Wherry
Journal:  Cell Rep Med       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.